Subscribe to our Newsletters !!

    Premas biotech

    ‘Made in India’ research initiative to seek to develop a vaccine against Covid-19 based on multi-antigenic approach

    Based on the biotech firm’s exclusive D-Crypt™ technology, this research methodology employs a modified version of baker’s yeast to produce the three antigens in a single host, thus making the potential vaccine easier to produce at mass scale and in a cost-effective manner compared to certain other vaccine candidates under development A team of researchers